《TRIPs协议修正案》的经济范畴困境

Difficult Economic Context of TRIPs Agreement Amendment

《TRIPs协议修正案》(简称《修正案》)面临一系列经济挑战。强制许可下的通用药品生产成本高于一般强制许可的生产成本,出于市场大小、药品捐赠、竞售药品、风险等经济因素的考虑,许多通用药品制造公司不愿意援引《修正案》及其所涉强制许可制度生产和出口药品。经济因素很大程度上影响了WTO成员方对《修正案》的实施。

The TRIPs Agreement Amendment is faced with a lot of economic challenges.The production cost of compulsory licensing under the TRIPs Agreement Amendment is higher than one of the ordinary compulsory licensing.Whether the WTO members enforce the TRIPs Agreement Amendment is based on several economic factors：competing for marketing drug production cost,risk,market size,donation and the inclination which some generic pharmaceutical manufacturers are unwilling to manufacture and export drug in conformity with the TRIPs Agreement Amendment and the similar compulsory licensing regime.